Navigation Links
Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
Date:12/13/2007

Achieves Statistically Significant ACR20, ACR50 & ACR70 Results

SOUTH SAN FRANCICSO, Calif., Dec. 13 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that its oral syk kinase inhibitor, R788 (tamatinib fosdium), has demonstrated statistically significant results in treating Rheumatoid Arthritis (RA) patients in a recently completed Phase 2 clinical trial. Groups treated with R788 at 100mg and 150mg po bid (orally, twice daily), showed higher ACR20, ACR50, ACR70 and DAS28 response rates than the placebo group. The efficacy results for the 100mg and the 150mg dose groups were fairly comparable. Dramatically, the onset of the effect in these dose groups occurred as early as one week after initiation of therapy. We believe that the significant ACR scores and good tolerability observed in this clinical trial, and the further benefit of oral delivery may make R788 a favorable alternative to the currently marketed biological agents.

Rigel will host a conference call today at 12:30 p.m. EST to discuss these results (see conference call details below).

"This clinical study has shown that R788 treatment can achieve impressive ACR response rates," said Elliott Grossbard, M.D., senior vice president of medical development at Rigel. "In this clinical trial both the 100mg and 150mg doses improved arthritis symptoms and did so quickly. We plan to initiate the next clinical trial with R788 in RA in 2008," he added.

Efficacy Results*

Treatment Assigned Number ACR 20 ACR 50 ACR 70 DAS28-CRP <2.6,

po bid (N) % (N) % (N) % (N) % (N)

Placebo 47 38% (18) 19% (9) 4% (2) 17% (8)

50 mg
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)...  In part four of a blog ... as a strategic asset, Mary Baxter, MBA, RPh ... Health,s Innovation Delivery Solutions business, discusses how expanding patient ... and patients. "Every hospital pharmacist knows that ... job in a value-based healthcare world," Baxter says. "For ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data ... new website design . The main website, along ... showcases the company,s new services and content relevant to ... a new streamlined design, viewers can now better understand ... health care practices and create a more visible platform ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4PMDS Announces New Website 2
(Date:8/30/2014)... According to Bloomberg , U.S. ... Takeda Pharmaceutical Co. and Eli Lilly & Co. to ... the drugmakers concealed information about a risk of bladder ... Allen v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), was ... Louisiana (Lafayette).* , According to Bloomberg, Takeda and Lilly ...
(Date:8/30/2014)... CA (PRWEB) August 30, 2014 Ticket Down ... vs. Chile exhibition match next Saturday at Levi's Stadium. ... for diehard soccer fans in the United States due to the ... in just about every major city. Many of these games ... in Brazil this past summer. , Levi’s Stadium is a brand ...
(Date:8/30/2014)... OH (PRWEB) August 30, 2014 United Theological ... first fully online degree, the Master of Theological Studies (MTS). ... in 2-3 years, is designed for students who wish to ... their understanding and capacity to serve the Church and community. ... degree, but now they can attend classes from any location ...
(Date:8/30/2014)... Patients suffering from vitiligo can now discover ... review published by Daily Gossip. , Vitiligo is ... is no wonder that numerous sufferers search for an ... is one of the most appreciated such methods at ... stop the spread of this disorder immediately, while completely ...
(Date:8/30/2014)... 2014 Daily Gossip magazine reveals in ... and panic attacks under control with a simple and ... describes this new method as an anxiety recovery ... and overcome general anxiety related disorders. , What ... fact that it can be accessed by users from ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2
... follicular lymphoma who continue on maintenance rituximab therapy ... who do not receive this treatment, according to ... 10 online issue of the Journal of ... with follicular lymphoma respond to initial therapy but ...
... PAUL, Minn., Feb. 10 The Minnesota Nurses Association ... agreement which addresses working conditions during emergency response situations. ... ensure adequate Registered Nurse staffing, the health and safety ... of a natural disaster, catastrophic event, pandemic illness or ...
... Researchers from Penn Medicine announced today the results ... of VRX496 at the 16th Conference on Retroviruses and ... gene therapy product being investigated for the treatment of ... to twelve subjects prior to a controlled scheduled treatment ...
... ASPS, Nearly 15-Million U.S. Working Women Considering Cosmetic ProceduresARLINGTON HEIGHTS, ... news of increasing layoffs, straining economic times, and a belief ... are looking at cosmetic medical procedures to give them a ... compiled by the American Society of Plastic Surgeons (ASPS) of ...
... rate in North Carolina may mimic rest of nation, , , TUESDAY, ... the rate of chronic low back pain has more than doubled ... authors say might reflect what,s happening in the country as a ... said Dr. Timothy S. Carey, a professor of medicine at the ...
... Feb. 10 A news conference to announce the ... to be conducted at UofL and Jewish Hospital will ... The location will be the Abell Administration Center second ... Health Sciences Campus.Speakers will include UofL President James Ramsey; ...
Cached Medicine News:Health News:Rituximab maintenance therapy improves survival in patients with relapsed follicular lymphoma 2Health News:Minnesota Nurses Association and Allina Hospitals and Clinics Forge Emergency Preparedness Agreement 2Health News:Penn Medicine presents HIV gene therapy trial data at CROI 2009 2Health News:Video: Women in the Workforce Link Cosmetic Surgery to Success 2Health News:Chronic Low Back Pain Is on the Rise 2Health News:Chronic Low Back Pain Is on the Rise 3
Use the Oculus Mesotest II before and after IOL or refractive surgery. Selectable Landolt ring positions. Accurate measurements in four contrast levels, with and without glare, independent of the pup...
... state-of-the-art electronic medical record the development of ... a proven, comprehensive electronic medical record designed ... at the point of care and to ... through the Internet. AmkaiCharts chronicles patient history, ...
... Systems Information Technologies invites ... yourself how it's award-winning ... - Practice Management (formerly ... simplify your office processes ...
... lamp is designed to for use with ... lamp offers the popular horizontal style light ... ReSeeVit family of slit lamps that offers ... capture clear, crisp digital images in the ...
Medicine Products: